What this instrument covers
The National Health (Growth Hormone Program) Special Arrangement Amendment (April Update) Instrument 2026 (F2026L00405) amended the rules governing the Growth Hormone Program under the National Health Act 1953. The program controls how growth hormone treatments are supplied and subsidised.
The instrument that was changed
This amendment made changes to the National Health (Growth Hormone Program) Special Arrangement 2025 (PB 112 of 2025). The source does not specify what particular changes were made to the program's conditions or eligibility criteria.
Dates
- In force from: 31 March 2026
- Repealed: 18 August 2026
The amendment applied between 31 March 2026 and 18 August 2026 only.
Key actions
- The full text of this amendment is available at https://www.legislation.gov.au/F2026L00405 - this is where businesses can confirm any changed conditions that applied during the period the instrument was in force.
- This instrument was repealed on 18 August 2026. The Federal Register of Legislation at https://www.legislation.gov.au is where the current version of the Growth Hormone Program Special Arrangement rules that replaced it can be found.
- The Department of Health, Disability and Ageing administers this program. The source does not provide a specific contact for this instrument.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.